Assessment of Rituximab Therapeutic Response Versus Conventional Treatment
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
Prospective interventional comparative study to compare the efficacy of Rituximab versus
Conventional treatment in Refractory Nephrotic Syndrome including patients on triple
immunosuppression protocols.